Page last updated: 2024-11-07

carbachol and Pulmonary Fibrosis

carbachol has been researched along with Pulmonary Fibrosis in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Namba, Y1
Togo, S1
Tulafu, M1
Kadoya, K1
Nagahama, KY1
Taka, H1
Kaga, N1
Orimo, A1
Liu, X1
Takahashi, K1
Barrio, J1
Cortijo, J1
Milara, J1
Mata, M1
Guijarro, R1
Blasco, P1
Morcillo, EJ1

Other Studies

2 other studies available for carbachol and Pulmonary Fibrosis

ArticleYear
Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes.
    Respiratory research, 2017, 03-11, Volume: 18, Issue:1

    Topics: Adrenergic beta-2 Receptor Antagonists; Aged; Carbachol; Dose-Response Relationship, Drug; Drug Ther

2017
In vitro tracheal hyperresponsiveness to muscarinic receptor stimulation by carbachol in a rat model of bleomycin-induced pulmonary fibrosis.
    Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:3

    Topics: Animals; Bleomycin; Bronchial Hyperreactivity; Calcium Signaling; Carbachol; Disease Models, Animal;

2006